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Introduction
The optimal catheter ablation approach for long-
standing persistent atrial fibrillation (AF) remains 
elusive despite significant advances made in our 
understanding of this arrhythmia. A recent sys-
tematic review highlighted the significant varia-
tion in procedural success rate both within and 
between techniques, necessitating repeat ablation 
procedures and anti-arrhythmic drugs to achieve 
improved outcomes in those with long-standing 
persistent AF [1]. Indeed, current expert consen-
sus statement recommended ablation beyond os-
tial pulmonary vein isolation for these patients 
[2]. Despite incorporating various substrate modi-
fication techniques which commonly include 
linear lesions and targeting of complex fraction-
ated electrograms, the reported success rates from 
various laboratories are still below par to those 
in paroxysmal AF patients [1]. Perhaps the often 
dilated and chronically remodeled atria in long-
standing persistent AF patients harbor complex 
structural substrates capable of maintaining the 
arrhythmia beyond amelioration even with ex-
tensive catheter ablation in some. Certainly, this 
reflects our incomplete understanding of the com-
plex mechanisms underlying this arrhythmia. 
Regardless of the approach, electrophysiologists 
must be clear of the endpoints for their chosen ab-
lation strategy. Pulmonary vein ablation remains 
the cornerstone in most catheter ablation strate-
gies with complete electrical isolation accepted as 
its goal and if linear lesions are attempted, com-
pleteness of lesion sets should be confirmed us-
ing activation mapping with appropriate pacing 
maneuvers [2]. Endpoints for electrogram guid-
ed ablation are less well defined but can include 
elimination of fractionated signals or transforma-
tion into discrete electrograms, and slowing or 
organization of local fibrillatory cycle length [3]. 
Apart from the above-mentioned electrophysi-
ological endpoints, termination of AF to sinus 
rhythm or atrial tachycardia has been pursued 
as procedural endpoint with the stepwise abla-
tion approach. Laboratories using this approach 
reported high long term success rate in up to 88% 
without anti-arrhythmic drugs despite the need 
for multiple procedures due to recurrent atrial 
tachycardias [3-6]. Specifically, from a prospec-
tive study of 153 consecutive patients, O’Neill 
and co-workers demonstrated that 95% of those 
with AF termination remained in sinus rhythm 
at a mean follow-up duration of 32 months as 
compared to just 52% in those without AF ter-
mination following repeat ablation procedures 
[6]. Likewise, in a smaller series of 88 patients by 
Rostock et al the overall success rate was 95% in 
those with as compared to 5% in those without 
termination of AF in two procedures and a mean 
follow-up duration of 20 months [5]. Therefore, 
termination of AF appeared to be prognosti-
cally important in long-standing persistent AF. 
In a recent study published in Heart Rhythm en-
titled “Atrial fibrillation termination as a proce-
dural endpoint during ablation in long-standing 
persistent atrial fibrillation”, Elayi and colleagues 
undertook a prospective multi-centre evaluation 
of the prognostic impact of AF termination dur-
ing ablation in a large cohort of 306 patients over 
a mean follow-up period of 25 months [7]. The ab-
lation strategy in this study consisted of pulmo-
nary vein antrum isolation followed by complex 
fractionated atrial electrograms ablation. They 
achieved AF termination in 178 patients (58%) 
at the first procedure. In total, long term sinus 
rhythm maintenance off anti-arrhythmic drugs 
was not significantly different between those with 
(68%, 121/178) and without (70%, 90/128) AF ter-
mination at the first procedure. In addition, no 
difference was observed whether sinus rhythm or 
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atrial tachycardia was achieved with AF termina-
tion during the initial ablation.  AF recurrence was 
seen in 57/178 (32%) and 38/128 (30%) patients with 
and without initial AF termination: 46/57 (81%) 
and 28/38 (74%) of these patients underwent a sec-
ond procedure whereby AF termination was again 
achieved in 26/46 (57%) and 15/28 (54%) respectively. 
Interestingly, long term success off anti-arrhythmic 
drugs after two procedures remained similar be-
tween those with (83%, 147/178) and without (82%, 
105/128) AF termination. Further analysis showed 
that if AF was terminated into atrial tachycardia 
during ablation, those with focal atrial tachycardia 
had better longer term success than those with mac-
ro-reentrant atrial tachycardia (83 vs. 57%, p=0.026). 
The results presented by Elayi et al appear dispa-
rate to the experience of the Bordeaux and Ham-
burg laboratories. However, the following funda-
mental differences need to be considered: First, 
the study population differed amongst these three 
studies with a younger cohort in the O’Neill series 
and what appears to be shorter duration of AF in 
patients from the O’Neill and Rostock reports. Sec-
ond, the mean baseline AF cycle length in the Elayi 
series was shortest amongst the 3 studies at 128ms, 
perhaps implying more remodeled atria. Third, 
utilization of anti-arrhythmic drugs in the peri-pro-
cedural and follow-up periods was different with 
exclusively no amiodarone use in the Elayi series. 
Fourth, although all studies aimed to terminate AF 
during the procedure, different ablation strategy 
was employed with pulmonary vein antrum isola-
tion followed by complex fractionated atrial elec-
trograms ablation in the Elayi report and stepwise 
ablation approach in the other two. Last, post-proce-
dural management strategy appears different with 
the Rostock series reporting use of DC cardioversion 
in the first 3 months for any arrhythmia recurrence.
Indeed, both the duration of continuous AF and 
baseline AF cycle length have been found to be pre-
dictive of maintenance of sinus rhythm by catheter 
ablation in a recent report [8]. Perhaps the more 
advanced underlying electrical and structural re-
modeling due to longer AF duration (> 2 years) in 
patients from the Elayi series portends a greater 
prognostic burden than achieving termination of AF 
during catheter ablation. This may in part account 
for their observations that atrial tachycardias of a 
focal mechanism had a better outcome than those 
of a re-entrant type given the complex atrial sub-
strate in their patients as evidenced by their short 
baseline AF cycle length further alluding to their 
arrhythmia chronicity. Another recent report on 
the reversibility of atrial electrical and structural 
remodeling due to chronic atrial stretch following 
removal of the stretch stimulus highlighted that 
the substrate predisposing to AF might be reversed 
[9]. On this note, the lack of use of amiodarone and 
DC cardioversion in the Elayi series would have 
reduced the opportunity for reverse atrial remod-
eling thereby confounding the benefits of achiev-
ing AF termination following catheter ablation. 
In summary, AF is a heterogeneous disease which 
requires a tailored management approach in the 
individual patient based on their predisposing 
risk profile and the nature and duration of their ar-
rhythmia.  Termination of AF during the stepwise 
ablation approach in patients with shorter dura-
tion of AF and longer baseline AF cycle length to-
gether with aggressive post-procedural rhythm 
control has shown great promise as a prognosti-
cally important ablation endpoint. Taken together 
with the findings by Elayi et al, the termination of 
AF as a procedural endpoint may not be the Holy 
Grail during the ablation of long-standing persis-
tent AF and will require further investigations. 
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